Business
Pfizer says trials show COVID-19 antiviral pill cuts hospitalisation and death risk by nearly 90 per cent – ABC News
Pfizer will ask regulators for the pill to be made available for global use as soon as possible after clinical trials suggested…
Pfizer says its experimental antiviral pill for COVID-19 cut rates of hospitalisation and death by nearly 90 per cent in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.
Key points:
- Pfizer says preliminary…
Continue Reading
-
Noosa News24 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants